BCG反応の予測

基本情報

NCT ID: NCT04564781
ステータス: 募集中
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 400
治験依頼者名: Cedars-Sinai Medical Center

概要

To date, there are no diagnostics capable of predicting treatment response to intravesical BCG. Because of this severe limitation, nearly 50% of patients treated with BCG fail therapy and will a) require additional intravesical therapy or b) require cystectomy. A urine-based diagnostic that possesses the potential to accurately identify patients who will respond favorably to intravesical BCG is desperately needed.

対象疾患

膀胱がん

依頼者（Sponsor）

National Cancer Institute (Nci)(NIH)

University Of California, San Francisco(OTHER)

Cedars-sinai Medical Center(OTHER)

University Of California, Los Angeles(OTHER)

Nonagen Bioscience(INDUSTRY)

Kyoto University(OTHER)

実施施設 (1)

Kyoto University

Kyoto, Kyoto, Japan(RECRUITING)